Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Despite knowing better, clinicians are still ordering broad food allergy panels that professional societies say shouldn't be used. A new survey found that 85% of ordering clinicians acknowledged these tests have high false-positive rates — yet 1,700 were still ordered at one institution in 2024 alone. The result? Unnecessary dietary restrictions, added stress, and extra costs for patients and families.
Despite clear guidance from professional societies recommending against broad food allergy panels, clinicians continue to order them at surprisingly high rates. A survey of 43 clinicians who ordered at least one such panel in 2024 — presented at the ACAAI Annual Scientific Meeting — found that the vast majority knew these tests carry high false-positive rates, yet ordered them anyway. Common reasons included patient or family requests, suspected IgE-mediated food allergy, and urticaria.
The gap between knowledge and practice was especially notable among nurse practitioners and physician assistants: 63% said they'd order a panel for a patient with eczema and a family history of food allergy, compared to just 30% of MDs and DOs — even though guidelines don't support this. Researchers are now calling for targeted education and EHR-level interventions, like removing panel orders or adding best-practice alerts, to help close this gap.
By the Numbers:
Why it matters: False positives from these panels can lead families to unnecessarily eliminate foods from their children's diets — ironically increasing the risk of developing true allergies. Overuse also drives up healthcare costs and patient anxiety, making this a meaningful concern for both clinical practice and patient wellbeing.